YTHDF2 and central nervous system cancer: In glioma, YTHDF2 stabilizes its protein through the EGFR/SRC/ERK signaling axis, thereby affecting tumor proliferation and other biological behaviors through LXRα-dependent cholesterol homeostasis [7].